These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15918022)

  • 1. Normal metabolism of apolipoprotein B100-containing lipoproteins despite qualitative abnormalities in type 1 diabetic men.
    Duvillard L; Florentin E; Lalanne-Mistrich ML; Petit JM; Baillot-Rudoni S; Brun-Pacaud A; Brun JM; Gambert P; Vergès B
    Diabetologia; 2005 Jul; 48(7):1366-72. PubMed ID: 15918022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
    Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study.
    Duvillard L; Pont F; Florentin E; Galland-Jos C; Gambert P; Vergès B
    Eur J Clin Invest; 2000 Aug; 30(8):685-94. PubMed ID: 10964160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.
    Zulewski H; Ninnis R; Miserez AR; Baumstark MW; Keller U
    J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes.
    Ouguerram K; Magot T; Zaïr Y; Marchini JS; Charbonnel B; Laouenan H; Krempf M
    J Pharmacol Exp Ther; 2003 Jul; 306(1):332-7. PubMed ID: 12684543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity.
    Pont F; Duvillard L; Florentin E; Gambert P; Vergès B
    Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1726-32. PubMed ID: 12377756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.
    Taskinen MR; Björnson E; Kahri J; Söderlund S; Matikainen N; Porthan K; Ainola M; Hakkarainen A; Lundbom N; Fermanelli V; Fuchs J; Thorsell A; Kronenberg F; Andersson L; Adiels M; Packard CJ; Borén J
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):962-975. PubMed ID: 33356392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the metabolism of apolipoprotein B100 in relation to insulin resistance in African American males.
    Sumner AE; Falkner B; Diffenderfer MR; Barrett PH; Marsh JB
    Proc Soc Exp Biol Med; 1999 Sep; 221(4):352-60. PubMed ID: 10460697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy.
    Taskinen MR; Matikainen N; Björnson E; Söderlund S; Inkeri J; Hakkarainen A; Parviainen H; Sihlbom C; Thorsell A; Andersson L; Adiels M; Packard CJ; Borén J
    Diabetologia; 2023 Dec; 66(12):2307-2319. PubMed ID: 37775612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes.
    Vergès B; Florentin E; Baillot-Rudoni S; Monier S; Petit JM; Rageot D; Gambert P; Duvillard L
    Diabetologia; 2008 Aug; 51(8):1382-90. PubMed ID: 18535816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
    Rubies-Prat J; Ordóñez-Llanos J; Martin S; Blanco-Vaca F; Molina L; Goday A; Pedro-Botet J
    Clin Exp Hypertens; 2001 Aug; 23(6):489-500. PubMed ID: 11478431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertriglyceridemia Results From an Impaired Catabolism of Triglyceride-Rich Lipoproteins in
    Vergès B; Vantyghem MC; Reznik Y; Duvillard L; Rouland A; Capel E; Vigouroux C
    Arterioscler Thromb Vasc Biol; 2024 Aug; 44(8):1873-1883. PubMed ID: 38899472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
    Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
    Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disturbance of apolipoprotein B100 containing lipoprotein metabolism in severe hyperlipidemic and lipodystrophic HIV patients on combined antiretroviral therapy: evidences of insulin resistance effect.
    Ouguerram K; Zair Y; Billon S; Chétiveaux M; Brunet-François C; Ngohou-Bach K; Allavena C; Reliquet V; Milpied B; Magot T; Raffi F; Krempf M
    Med Chem; 2008 Nov; 4(6):544-50. PubMed ID: 18991738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of n-3 fatty acids on metabolism of apoB100-containing lipoprotein in type 2 diabetic subjects.
    Ouguerram K; Maugeais C; Gardette J; Magot T; Krempf M
    Br J Nutr; 2006 Jul; 96(1):100-6. PubMed ID: 16869997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B-100 in men.
    Millar JS; Lichtenstein AH; Cuchel M; Dolnikowski GG; Hachey DL; Cohn JS; Schaefer EJ
    J Lipid Res; 1995 Jun; 36(6):1155-67. PubMed ID: 7665994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of very low density lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients; effects of blood glucose optimisation.
    Rivellese A; Riccardi G; Romano G; Giacco R; Patti L; Marotta G; Annuzzi G; Mancini M
    Diabetologia; 1988 Dec; 31(12):884-8. PubMed ID: 3240843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of apolipoprotein B100 metabolism between continuous subcutaneous and intraperitoneal insulin therapy in type 1 diabetes.
    Duvillard L; Florentin E; Baillot-Rudoni S; Lalanne-Mistrich ML; Brun-Pacaud A; Petit JM; Brun JM; Gambert P; Vergès B
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5761-4. PubMed ID: 16091481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type I diabetic patients.
    Guerci B; Igau B; Ziegler O; Crea T; Fruchart JC; Drouin P; Fievet C
    Metabolism; 1996 Apr; 45(4):430-4. PubMed ID: 8609827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.